• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Is increased BMI associated with reduced risk of premenopausal breast cancer?

Bioengineer by Bioengineer
June 21, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: Higher body mass index (BMI), especially in early adulthood, may be associated with reduced risk for premenopausal breast cancer.

Why The Research Is Interesting: Breast cancer is the most commonly diagnosed cancer among women. Breast cancer's origin is complex and it includes a wide range of factors, among them how much body fat a woman has, a measure often assessed by BMI (a calculation of weight in kilograms divided by height in meters squared). Previous research suggests increasing BMI may be associated with reduced risk for premenopausal breast cancer but increased risk after menopause. This study sought to undertake a more rigorous and systematic analysis of the association between BMI and risk of premenopausal breast cancer using pooled data from 19 studies.

Who and When: 758,592 premenopausal women from 19 studies (recruited from 1963 to 2013); there were 13,082 new cases of breast cancer over roughly nine years of follow-up per participant

What (Study Measures and Outcomes): BMI at ages 18 to 24, 25 to 34, 35 to 44 and 45 to 54 (exposures); invasive or noninvasive (in situ) premenopausal breast cancer

Study Design: This was an observational study. Researchers were not intervening for purposes of the study and cannot totally control for all the natural differences that could explain the study results.

Authors: Premenopausal Breast Cancer Collaborative Group (Minouk J. Schoemaker, Ph.D., of the Institute of Cancer Research, London, United Kingdom, is the corresponding author)

Results: The analysis suggests an "inverse association" of breast cancer risk with BMI for women between the ages of 18 and 54, which means breast cancer risk decreased as BMI increased. The association was strongest for BMI in early adulthood between the ages of 18 and 24.

Limitations: The study used BMI as its measure but women with the same BMI can have different body fat distributions and overall levels of body fat; weight was often self-reported and some women over report or under report their weight

Study Conclusions: Study authors are not advocating weight gain as a way to reduce premenopausal breast cancer risk. Understanding the reasons for the association seen between BMI and premenopausal breast cancer risk could potentially help to identify risk factors that might be modified.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jamaoncol.2018.1771)

Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Want to embed a link to this study in your story?: Links will be live at the embargo time http://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2018.1771

Media Contact

Jamie Lederhose
[email protected]

@JAMAOnc

Share12Tweet8Share2ShareShareShare2

Related Posts

Deep Learning Uncovers Tetrahydrocarbazoles as Potent Broad-Spectrum Antitumor Agents with Click-Activated Targeted Cancer Therapy Approach

February 7, 2026

Newly Discovered Limonoid DHL-11 from Munronia henryi Targets IMPDH2 to Combat Triple-Negative Breast Cancer

February 7, 2026

New Discovery Reveals Why Ovarian Cancer Spreads Rapidly in the Abdomen

February 6, 2026

New Study Finds Americans Favor In-Clinic Screening Over At-Home Tests for Cervical Cancer

February 6, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Pediatric Emergency Care Quality in Ethiopia

TPMT Expression Predictions Linked to Azathioprine Side Effects

Improving Dementia Care with Enhanced Activity Kits

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.